D-烯丙基甘氨酸结构式
|
常用名 | D-烯丙基甘氨酸 | 英文名 | D-Allylglycine |
---|---|---|---|---|
CAS号 | 54594-06-8 | 分子量 | 115.131 | |
密度 | 1.1±0.1 g/cm3 | 沸点 | 230.9±33.0 °C at 760 mmHg | |
分子式 | C5H9NO2 | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | 93.5±25.4 °C |
D-烯丙基甘氨酸用途H-D-Gly(烯丙基)-OH是甘氨酸(HY-Y0966)衍生物[1]。 |
中文名 | D-烯丙基甘氨酸 |
---|---|
英文名 | D-Allylglycine |
中文别名 | D-Alpha-烯丙基甘氨酸 | (R)-2-氨基-4-戊烯酸 | 2-烯丙基-D-甘氨酸 | D-C-烯丙基氨基乙酸 | D-ALPHA-烯丙基甘氨酸 | D-α-烯丙基甘氨酸 |
英文别名 | 更多 |
描述 | H-D-Gly(烯丙基)-OH是甘氨酸(HY-Y0966)衍生物[1]。 |
---|---|
相关类别 | |
体外研究 | 氨基酸和氨基酸衍生物已被商业化用作能量补充剂。它们影响合成代谢激素的分泌、运动期间的燃料供应、压力相关任务期间的精神表现,并防止运动引起的肌肉损伤。它们被认为是有益的能生膳食物质[1]。 |
参考文献 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 230.9±33.0 °C at 760 mmHg |
分子式 | C5H9NO2 |
分子量 | 115.131 |
闪点 | 93.5±25.4 °C |
精确质量 | 115.063332 |
PSA | 49.33000 |
LogP | 0.26 |
外观性状 | 灰白色固体 |
蒸汽压 | 0.0±1.0 mmHg at 25°C |
折射率 | 1.484 |
储存条件 | 2~8°C |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危害码 (欧洲) | Xi |
风险声明 (欧洲) | R36/37/38 |
安全声明 (欧洲) | 22-24/25-36-26 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
海关编码 | 2922499990 |
海关编码 | 2922499990 |
---|---|
中文概述 | 2922499990 其他氨基酸及其酯及它们的盐(含有一种以上含氧基的除外). 增值税率:17.0% 退税率:9.0% 监管条件:AB(入境货物通关单,出境货物通关单) 最惠国关税:6.5% 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装 |
监管条件 | A.入境货物通关单 B.出境货物通关单 |
检验检疫 | P.进境动植物、动植物产品检疫 Q.出境动植物、动植物产品检疫 R.进口食品卫生监督检验 S.出口食品卫生监督检验 M.进口商品检验 N.出口商品检验 |
Summary | HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |
Drug design, in vitro pharmacology, and structure-activity relationships of 3-acylamino-2-aminopropionic acid derivatives, a novel class of partial agonists at the glycine site on the N-methyl-D-aspartate (NMDA) receptor complex.
J. Med. Chem. 52 , 5093-107, (2009) Retaining agonistic activity at the glycine coagonist site of the NMDA receptor in molecules derived from glycine or d-serine has proven to be difficult because in the vicinity of the alpha-amino acid... |
|
In vivo neurochemical evidence that newly synthesised GABA activates GABA(B), but not GABA(A), receptors on dopaminergic nerve endings in the nucleus accumbens of freely moving rats.
Neuropharmacology 62 , 907-913, (2012) GABA released from accumbal GABAergic interneurons plays an inhibitory role in the regulation of dopamine efflux through GABA(B) and GABA(A) receptors located on accumbal dopaminergic nerve endings. T... |
|
Cyclic opioid peptide agonists and antagonists obtained via ring-closing metathesis.
Chem. Biol. Drug Des. 74 , 329-334, (2009) The opioid peptide H-Tyr-c[D-Cys-Phe-Phe-Cys]NH(2) cyclized via a methylene dithiother is a potent and selective mu opioid agonist (Przydial M.J. et al., J Peptide Res, 66, 2005, 255). Dicarba analogu... |
D-a-Allylglycine |
4-Pentenoic acid, 2-amino-, (R)- |
(R)-allylglycine |
(R)-α-Allylglycine |
3-VINYL-D-ALANINE |
H-ALLYL-D-GLYCINE |
(R)-2-Allylglycine |
(R)-2-amino-4-pentenoic acid |
H-D-Gly(Ally)-OH |
(2R)-2-Amino-4-pentenoic acid |
H-D-ALGLY-OH |
(R)-2-Aminopent-4-enoic acid |
(2R)-2-aminopent-4-enoic acid |
4-Pentenoic acid, 2-amino-, (2R)- |
D-Allyiglycine |
D-C-ALLYLGLYCINE |
MFCD00063104 |
H-D-GLY(ALLYL)-OH |
(R)-2-allyl-Gly |
D-2-Amino-4-pentenoic acid |